Ocumension Therapeutics Announces Demise of Lianming HE, Independent Non-Executive Director, Chairman of the Remuneration Committee and Member of the Audit Committee and Nomination Committee

The board of directors of Ocumension Therapeutics announced with the deepest sorrow that Mr. Lianming HE ("Mr. He"), an independent non-executive director, the chairman of the remuneration committee and a member of the audit committee and nomination committee of the Company, passed away on March 30, 2022.